68Ga-FAPI PET/CT versus 18F-FDG PET/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast/Acquired Immunodeficiency Syndrome
World Journal of Nuclear Medicine · 01.09.2024 · 23 (03) · 217-219
DOI: 10.1055/s-0044-1787718 ↗Kurz gefasst
Fallbericht in der Zeitschrift World Journal of Nuclear Medicine, erschienen am 01.09.2024. Verfasst von Gopinathraj Gunasekaran und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, PET-CT and Theranostics, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gallium-68 (68Ga)-fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET) images the cancer-associated fibroblast that forms a vital component of the tumor microenvironment. It is known that 68Ga-FAPI PET can aid in differentiating reactive lymph nodes from metastatic lymph nodes. 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) is still the most commonly used PET radiopharmaceutical in the evaluation of a wide range of malignancies including breast carcinoma. Reactive lymph nodes may also show FDG uptake which can hinder optimal assessment for metastatic involvement. We report an interesting case of invasive ductal carcinoma of the right breast with associated World Health Organization clinical stage I acquired immunodeficiency syndrome for which 18F-FDG PET/CT and 68Ga-FAPI PET/CT were done.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, PET-CT and Theranostics, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India.
ORCID-Profile: Gopinathraj Gunasekaran
Zitieren
APA
Gunasekaran, G., & Amalachandran, J. (2024). 68Ga-FAPI PET/CT versus 18F-FDG PET/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast/Acquired Immunodeficiency Syndrome. World Journal of Nuclear Medicine, 23(03), 217-219. https://doi.org/10.1055/s-0044-1787718
Vancouver
Gunasekaran G, Amalachandran J. 68Ga-FAPI PET/CT versus 18F-FDG PET/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast/Acquired Immunodeficiency Syndrome. World Journal of Nuclear Medicine. 2024;23(03):217-219. doi:10.1055/s-0044-1787718
BibTeX
@article{Gunasekaran2024,
author = {Gunasekaran, Gopinathraj and Amalachandran, Jaykanth},
title = {68Ga-FAPI PET/CT versus 18F-FDG PET/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast/Acquired Immunodeficiency Syndrome},
journal = {World Journal of Nuclear Medicine},
year = {2024},
volume = {23},
number = {03},
pages = {217--219},
doi = {10.1055/s-0044-1787718}
}
EUVIMED